Home Applications 219379 Application 219379
Type NDA
Sponsor SPRINGWORKS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 GOMEKLI MIRDAMETINIB TABLET, FOR SUSPENSION;ORAL 1MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219379-001 GOMEKLI MIRDAMETINIB 1MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2025-02-11
Orange Book patents# Current patent rows page 1 of 1 · 21 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219379-001 NCE 2030-02-11 N219379-001 ODE-488 2032-02-11
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219379-001 GOMEKLI 1MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2025-02-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 GOMEKLI 1MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2025-02-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219379-001 GOMEKLI 1MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2025-02-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219379-001 GOMEKLI 1MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2025-02-11 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219379-001 GOMEKLI 1MG TABLET, FOR SUSPENSION / ORAL RLD, RS 2025-02-11 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 94 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219379-001 11066358 2041-02-17 Drug substance 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 11084780 2041-02-17 Drug substance 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 11453641 2041-02-17 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 11571402 2041-02-17 Drug product 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 11806321 2041-02-17 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 11819487 2041-02-17 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12011424 2041-02-17 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12037306 2041-02-17 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12090128 2041-02-17 U-4130 Drug product 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12263146 2041-02-17 U-4130 2025-04-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12295925 2041-02-17 U-4130 2025-05-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12357597 2041-02-17 U-4130 2025-07-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 11839595 2043-03-16 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 11883375 2043-03-16 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12220390 2043-03-16 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12257215 2043-03-16 U-4130 2025-04-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12324791 2043-03-16 U-4130 2025-06-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 11806322 2043-04-09 U-4130 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12029711 2044-03-15 U-4130 Drug product 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 12390430 2044-10-10 U-4130 2025-08-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11066358 2041-02-17 Drug substance 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11084780 2041-02-17 Drug substance 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11453641 2041-02-17 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11571402 2041-02-17 Drug product 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11806321 2041-02-17 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11819487 2041-02-17 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12011424 2041-02-17 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12037306 2041-02-17 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12090128 2041-02-17 U-4130 Drug product 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12263146 2041-02-17 U-4130 2025-04-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12295925 2041-02-17 U-4130 2025-05-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12357597 2041-02-17 U-4130 2025-07-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11839595 2043-03-16 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11883375 2043-03-16 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12220390 2043-03-16 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12257215 2043-03-16 U-4130 2025-04-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12324791 2043-03-16 U-4130 2025-06-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 11806322 2043-04-09 U-4130 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12029711 2044-03-15 U-4130 Drug product 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 12390430 2044-10-10 U-4130 2025-08-20 31067a03dcf5…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219379-001 NCE 2030-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219379-001 ODE-488 2032-02-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 NCE 2030-02-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219379-001 ODE-488 2032-02-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219379-001 NCE 2030-02-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219379-001 ODE-488 2032-02-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219379-001 NCE 2030-02-11 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219379-001 NCE 2030-02-11 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219379-001 ODE-488 2032-02-11 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Gomekli MIRDAMETINIB SpringWorks Therapeutics, Inc. 4c41bf90-5fa7-4935-a95c-e047ea6bbf8e 2026-07-10 Warnings, Adverse reactions Exact identifier application applno (NDA): 219379 application number: NDA219379
Documents# Document, Submission type, Date table Document Submission type Date 81692 ORIG 2025-03-24 81691 ORIG 2025-03-24 81220 ORIG 2025-02-12 81218 ORIG 2025-02-12